Skip to content

Analysis of the feasibility and safety of day surgery for benign ovarian tumors based on enhanced recovery after surgery strategies and single port laparoscopic techniques

Analysis of the feasibility and safety of day surgery for benign ovarian tumors based on enhanced recovery after surgery strategies and single port laparoscopic techniques

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100041987
Enrollment
Unknown
Registered
2021-01-11
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign ovarian tumor

Interventions

case series:ERAS + single port laparoscopy + day surgery

Sponsors

Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 65 Years

Inclusion criteria

Inclusion criteria: 1) Aged < 65 years; 2) With or without clinical symptoms such as abdominal distension, abdominal pain, etc.; 3) Color Doppler ultrasound or CT indicates that the attachment is cystic or solid mass, 5~12cm in diameter; 4) The tumor markers are normal or slightly elevated; 5) American Society of Anesthesiologists (A) Grade I-II; 6) Patients who are willing to choose day surgery; 7) Patients can understand the program and are willing to participate in the study, and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1) Body temperature > 37.4 degrees C; 2) Hb < 80g/L; 3) Those who are highly suspected of malignant tumors; 4) Those with internal and surgical complications such as hypertension, diabetes, heart disease, etc., which have not been effectively controlled; 5) Acute genital tract inflammation; 6) People with multiple history of abdominal surgery and severe pelvic adhesions; 7) Participated in other clinical trials within three months before participating in this experiment; 8) There has been a mental illness or drug abuse that may affect compliance with the requirements of this test; 9) Other investigators consider it inappropriate to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
operation time;Intraoperative blood loss;Perioperative complications;Whether to transfer to porous laparoscopy or open surgery;Whether to transfer to the general ward;Whether to return to surgery unplanned;visual analoge scale score for postoperative pain;Hospital stay;Whether to delay discharge;patient's life quality scale;Rehospitalization rate 30 days after surgery;Patient satisfaction;

Secondary

MeasureTime frame
First exhaust time after operation;Time to get out of bed for the first time after surgery;Time of first meal after operation;Hospital costs;

Countries

China

Contacts

Public ContactXiaoqin Gan

Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China

316112248@qq.com+86 13980672233

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026